127 related articles for article (PubMed ID: 1567485)
1. Immunomodulation and drug acetylation: influence of the immunomodulator tilorone on hepatic, renal and blood N-acetyltransferase activity and on hepatic cytosolic acetyl coenzyme A content.
Drobitch RK; Tomilo M; Svensson CK
Biochem Pharmacol; 1992 Apr; 43(7):1643-8. PubMed ID: 1567485
[TBL] [Abstract][Full Text] [Related]
2. Effect of the immunomodulator tilorone on the in vivo acetylation of procainamide in the rat.
Svensson CK; Knowlton PW
Pharm Res; 1989 Jun; 6(6):477-80. PubMed ID: 2474808
[TBL] [Abstract][Full Text] [Related]
3. Effects of the immunomodulator tilorone on the acetylation of 2-aminofluorene and DNA-2-aminofluorene adducts in the rats.
Chung JG; Chang HL; Yeh CC; Lu HF; Chang CC; Tsai HD
Anticancer Res; 2000; 20(1A):467-73. PubMed ID: 10769698
[TBL] [Abstract][Full Text] [Related]
4. Effect of streptolysin-O-on rat hepatic acetyl coenzyme-A: arylamine N-acetyltransferase and cytochrome P-450 2B 1/2 activities ex vivo.
Drobitch RK; Divakaruni P; Svensson CK
Immunopharmacol Immunotoxicol; 1998 Feb; 20(1):159-71. PubMed ID: 9543706
[TBL] [Abstract][Full Text] [Related]
5. Bioactivation of N-arylhydroxamic acids by rat hepatic N-acetyltransferase. Detection of multiple enzyme forms by mechanism-based inactivation.
Wick MJ; Hanna PE
Biochem Pharmacol; 1990 Mar; 39(6):991-1003. PubMed ID: 2322300
[TBL] [Abstract][Full Text] [Related]
6. Acetylator genotype-dependent metabolic activation of carcinogenic N-hydroxyarylamines by S-acetyl coenzyme A-dependent enzymes of inbred hamster tissue cytosols: relationship to arylamine N-acetyltransferase.
Hein DW; Flammang TJ; Kirlin WG; Trinidad A; Ogolla F
Carcinogenesis; 1987 Dec; 8(12):1767-74. PubMed ID: 3677303
[TBL] [Abstract][Full Text] [Related]
7. Kinetics of acetyl coenzyme A:arylamine N-acetyltransferase from rapid and slow acetylator frog tissues.
Ho CC; Lin TH; Lai YS; Chung JG; Levy GN; Weber WW
Drug Metab Dispos; 1996 Feb; 24(2):137-41. PubMed ID: 8742223
[TBL] [Abstract][Full Text] [Related]
8. Dapsone acetylation by human liver arylamine N-acetyltransferases and interaction with antiopportunistic infection drugs.
Palamanda JR; Hickman D; Ward A; Sim E; Romkes-Sparks M; Unadkat JD
Drug Metab Dispos; 1995 Apr; 23(4):473-7. PubMed ID: 7600914
[TBL] [Abstract][Full Text] [Related]
9. Kinetic characterization of acetylator genotype-dependent and -independent N-acetyltransferase isozymes in homozygous rapid and slow acetylator inbred hamster liver cytosol.
Trinidad A; Kirlin WG; Ogolla F; Andrews AF; Yerokun T; Ferguson RJ; Brady PK; Hein DW
Drug Metab Dispos; 1989; 17(3):238-47. PubMed ID: 2568903
[TBL] [Abstract][Full Text] [Related]
10. Induction of sulfamethazine acetylation by hydrocortisone in the rabbit.
Reeves PT; Minchin RF; Ilett KF
Drug Metab Dispos; 1988; 16(1):110-5. PubMed ID: 2894938
[TBL] [Abstract][Full Text] [Related]
11. Immunological evidence for N-acetyltransferase isozymes in the rabbit.
Reeves PT; Kinnear BF; Minchin RF; Ilett KF
Mol Pharmacol; 1991 Jan; 39(1):42-8. PubMed ID: 1987451
[TBL] [Abstract][Full Text] [Related]
12. Genetic control of acetyl coenzyme A-dependent arylamine N-acetyltransferase, hydrazine N-acetyltransferase, and N-hydroxy-arylamine O-acetyltransferase enzymes in C57BL/6J, A/J, AC57F1, and the rapid and slow acetylator A.B6 and B6.A congenic inbred mouse.
Hein DW; Trinidad A; Yerokun T; Ferguson RJ; Kirlin WG; Weber WW
Drug Metab Dispos; 1988; 16(3):341-7. PubMed ID: 2900723
[TBL] [Abstract][Full Text] [Related]
13. The effect of hydralazine and other drugs on the kinetics of procainamide acetylation by rat liver and kidney N-acetyltransferase.
Schneck DW; Sprouse JS; Hayes AH; Shiroff RA
J Pharmacol Exp Ther; 1978 Jan; 204(1):212-8. PubMed ID: 619131
[TBL] [Abstract][Full Text] [Related]
14. N-acetylation pharmacogenetics. Michaelis-Menten constants for arylamine drugs as predictors of their N-acetylation rates in vivo.
Andres HH; Weber WW
Drug Metab Dispos; 1986; 14(4):382-5. PubMed ID: 2873982
[TBL] [Abstract][Full Text] [Related]
15. Effects of aspirin on the in vitro and in vivo acetylation of 2-aminofluorene in Sprague-Dawley rats.
Lin SS; Yu CS; Wu JY; Tyan YS; Hsia TC; Lin WC; Chung JG
In Vivo; 2005; 19(2):475-81. PubMed ID: 15796213
[TBL] [Abstract][Full Text] [Related]
16. Acetyl coenzyme A-dependent metabolic activation of N-hydroxy-3,2'-dimethyl-4-aminobiphenyl and several carcinogenic N-hydroxy arylamines in relation to tissue and species differences, other acyl donors, and arylhydroxamic acid-dependent acyltransferases.
Flammang TJ; Kadlubar FF
Carcinogenesis; 1986 Jun; 7(6):919-26. PubMed ID: 3708755
[TBL] [Abstract][Full Text] [Related]
17. Purification of hepatic polymorphic arylamine N-acetyltransferase from homozygous rapid acetylator inbred hamster: identity with polymorphic N-hydroxyarylamine-O-acetyltransferase.
Trinidad A; Hein DW; Rustan TD; Ferguson RJ; Miller LS; Bucher KD; Kirlin WG; Ogolla F; Andrews AF
Cancer Res; 1990 Dec; 50(24):7942-9. PubMed ID: 2253236
[TBL] [Abstract][Full Text] [Related]
18. Effect of H2-receptor antagonists on rat liver cytosolic acetyl CoA:arylamine N-acetyltransferase activity.
Svensson CK; Tomilo M
Drug Metab Dispos; 1992; 20(1):74-8. PubMed ID: 1371435
[TBL] [Abstract][Full Text] [Related]
19. Glucocorticoid induction of hepatic acetyl CoA:arylamine N-acetyltransferase activity in the rat.
Zaher H; Svensson CK
Res Commun Chem Pathol Pharmacol; 1994 Feb; 83(2):195-208. PubMed ID: 8202632
[TBL] [Abstract][Full Text] [Related]
20. Ethanol interaction with drug acetylation in vivo and in vitro.
Olsen H; Mørland J
Pharmacol Biochem Behav; 1983; 18 Suppl 1():295-300. PubMed ID: 6634843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
